Cardlytics, Inc.·4

Feb 20, 5:12 PM ET

Lynton Nicholas Hollmeyer 4

Research Summary

AI-generated summary

Updated

Cardlytics (CDLX) Chief Legal & Privacy Officer Lynton Hollmeyer Receives Award

What Happened
Lynton Nicholas Hollmeyer, Cardlytics' Chief Legal & Privacy Officer, received a grant of 220,000 restricted stock units (RSUs) on February 18, 2026 (transaction reported on Feb 20, 2026). The RSUs were issued at $0.00 cash cost to the recipient (a compensatory award/derivative grant), meaning no purchase price was paid at grant.

Key Details

  • Transaction date: 2026-02-18; Form 4 filed: 2026-02-20 (filed within the normal 2-business-day window).
  • Security: 220,000 RSUs granted (derivative award; reported as Code A). Reported acquisition price: $0.00.
  • Shares owned after transaction: Not specified in the filing.
  • Footnote F1: Each RSU represents a contingent right to receive one share of Cardlytics common stock.
  • Footnote F2: The RSU award vests in equal amounts quarterly over a two-year period through April 1, 2028, subject to continued employment.
  • No indication of tax withholding, immediate sale, or a 10b5-1 plan in the filing.

Context
RSUs are a compensatory equity award that convert to shares only when they vest; this grant does not represent immediate tradable stock. Such awards are common for executive compensation and should be interpreted as part of pay, not a direct market purchase or sale.